Anti-NRG2/ DON1/ HRG2 monoclonal antibody

Anti-NRG2/ DON1/ HRG2 antibody for FACS & in-vivo assay

Target products collectionGo to NRG2/NRG2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0904-Ab-1/ GM-Tg-hg-MP0904-Ab-2Anti-Human NRG2 monoclonal antibodyHuman
GM-Tg-rg-MP0904-Ab-1/ GM-Tg-rg-MP0904-Ab-2Anti-Rat NRG2 monoclonal antibodyRat
GM-Tg-mg-MP0904-Ab-1/ GM-Tg-mg-MP0904-Ab-2Anti-Mouse NRG2 monoclonal antibodyMouse
GM-Tg-cynog-MP0904-Ab-1/ GM-Tg-cynog-MP0904-Ab-2Anti-Cynomolgus/ Rhesus macaque NRG2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0904-Ab-1/ GM-Tg-felg-MP0904-Ab-2Anti-Feline NRG2 monoclonal antibodyFeline
GM-Tg-cang-MP0904-Ab-1/ GM-Tg-cang-MP0904-Ab-2Anti-Canine NRG2 monoclonal antibodyCanine
GM-Tg-bovg-MP0904-Ab-1/ GM-Tg-bovg-MP0904-Ab-2Anti-Bovine NRG2 monoclonal antibodyBovine
GM-Tg-equg-MP0904-Ab-1/ GM-Tg-equg-MP0904-Ab-2Anti-Equine NRG2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0904-Ab-1/ GM-Tg-hg-MP0904-Ab-2; GM-Tg-rg-MP0904-Ab-1/ GM-Tg-rg-MP0904-Ab-2;
GM-Tg-mg-MP0904-Ab-1/ GM-Tg-mg-MP0904-Ab-2; GM-Tg-cynog-MP0904-Ab-1/ GM-Tg-cynog-MP0904-Ab-2;
GM-Tg-felg-MP0904-Ab-1/ GM-Tg-felg-MP0904-Ab-2; GM-Tg-cang-MP0904-Ab-1/ GM-Tg-cang-MP0904-Ab-2;
GM-Tg-bovg-MP0904-Ab-1/ GM-Tg-bovg-MP0904-Ab-2; GM-Tg-equg-MP0904-Ab-1/ GM-Tg-equg-MP0904-Ab-2
Products NameAnti-NRG2 monoclonal antibody
Formatmab
Target NameNRG2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NRG2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NRG2/ DON1/ HRG2 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP0904-Ag-1neuregulin 2 (NRG2) protein


    Target information

    Target IDGM-MP0904
    Target NameNRG2
    Gene ID9542,100042150,432361,694995,487158,101090986,783452,100072444
    Gene Symbol and SynonymsDON1,HRG2,NRG2,NTAK,NTAK alpha1,NTAK alpha2a,NTAK_alpha2a
    Uniprot AccessionO14511,O35569
    Uniprot Entry NameNRG2_HUMAN,NRG2_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000158458
    Target ClassificationN/A

    The target: NRG2, gene name: NRG2, also named as DON1, HRG2, NTAK. This gene encodes a novel member of the neuregulin family of growth and differentiation factors. Through interaction with the ERBB family of receptors, this protein induces the growth and differentiation of epithelial, neuronal, glial, and other types of cells. The gene consists of 12 exons and the genomic structure is similar to that of neuregulin 1, another member of the neuregulin family of ligands. The products of these genes mediate distinct biological processes by acting at different sites in tissues and eliciting different biological responses in cells. This gene is located close to the region for demyelinating Charcot-Marie-Tooth disease locus, but is not responsible for this disease. Alternative transcript variants encoding distinct isoforms have been described. [provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.